Rare Diseases Symptoms Automatic Extraction

A novel method for the large-scale production of PG-CNP37, a C-type natriuretic peptide analogue.

[achondroplasia]

Achondroplasia is the most common form of human dwarfism caused by a mutation in the fibroblast growth factor receptor 3 (FGFR3), resulting in abnormal endochondral bone formation. C-type natriuretic peptide (CNP) is a potent stimulator of endochondral bone growth and represents a potential therapy for achondroplasia. We have developed a novel, simple and cost effective method to produce a CNP analogue, PG-CNP37, at a large scale from Escherichia coli. A PG-CNP37 fusion protein was over-expressed as inclusion bodies in E. coli, which were purified then cleaved by formic acid to release the PG-CNP37 peptide. Approximately 0.5g of 95% pure, soluble and active PG-CNP37 peptide was produced from 1L of culture using this method and may represent a viable means for large-scale production of other therapeutic peptides.

Diseases presenting "common form" symptom

  • achondroplasia
  • alexander disease
  • benign recurrent intrahepatic cholestasis
  • cadasil
  • child syndrome
  • classical phenylketonuria
  • cutaneous mastocytosis
  • erythropoietic protoporphyria
  • familial mediterranean fever
  • hereditary cerebral hemorrhage with amyloidosis
  • hodgkin lymphoma, classical
  • holt-oram syndrome
  • homocystinuria without methylmalonic aciduria
  • oral submucous fibrosis
  • pendred syndrome
  • primary hyperoxaluria type 1
  • severe combined immunodeficiency
  • thoracic outlet syndrome

You can validate or delete this automatically detected symptom